Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

A Phase Ib/II Study of the BCL-2 Inhibitor Venetoclax in Combination with Standard Intensive AML Induction/Consolidation Therapy with FLAG-IDA in Patients with Newly Diagnosed or Relapsed/Refractory AML

Iman Aboudalle, MD, Marina Y Konopleva, MD PhD, Tapan M. Kadia, MD, Kiran Naqvi, MDMPH, Kenneth Vaughan, RN, Mehmet Kurt, RN, Antonio Cavazos, Sherry A. Pierce, BSN, BA, Koichi Takahashi, MD, Lucia Masarova, MD, Musa E. Yilmaz, MD, Elias Jabbour, MD, Guillermo Garcia-Manero, MD, Steven M. Kornblau, MD, Farhad Ravandi, MD, Jorge Cortes, MD, Hagop M. Kantarjian, MD, Courtney D. DiNardo, MD MSc

Blood (2019) 134 (Supplement_1): 176.

https://doi.org/10.1182/blood-2019-121780

Published: 2019

Journal Articles

Impact of Primary Antibacterial Prophylaxis on Neutropenic Fever, Infections, and Antimicrobial Resistance in Newly Diagnosed AML Patients

Jessica Caro, MD, Erin Moshier, MS, Douglas Tremblay, MD, Alexander Coltoff, MD, Guido Lancman, MD, Meenakshi Rana, MD, John Mascarenhas, MD, Samantha Jacobs, MD

Blood (2019) 134 (Supplement_1): 3849.

https://doi.org/10.1182/blood-2019-123435

Published: 2019

Journal Articles

Soluble C5b-9 As a Prognostic Biomarker for Thrombotic Microangiopathy at the Onset of Graft-Versus-Host Disease

Ang Li, MD, Qian Vicky Wu, PhD, Tristan Hilton, Emily Pao, MS, Martin J Schmidt, PhD, Noel S Weiss, Stephanie J. Lee, MD MPH, Jingfei Dong, MD PhD, Sangeeta R Hingorani, MD MPH

Blood (2019) 134 (Supplement_1): 40.

https://doi.org/10.1182/blood-2019-128090

Published: 2019

Journal Articles

Venetoclax in Combination with FLAG-IDA Chemotherapy (FLAG-V-I) for Fit, Relapsed/Refractory AML Patients: Interim Results of a Phase 1b/2 Dose Escalation and Expansion Study

Courtney D. DiNardo, MD MSc, Maher Albitar, MD, Tapan M. Kadia, MD, Kiran Naqvi, MD MPH, Kenneth Vaughan, RN, Antonio Cavazos, MSc, Sherry A. Pierce, BSN, BA, Koichi Takahashi, MD, Steven M. Kornblau, MD, Farhad Ravandi, MD, Jorge E. Cortes, MD, Hagop M. Kantarjian, MD, Marina Y. Konopleva, MD PhD

Blood (2018) 132 (Supplement 1): 4048.

https://doi.org/10.1182/blood-2018-99-114812

Published: 2018

Journal Articles

Impact of Omitting Prophylactic Antibiotics, to Preserve Gut Microbiota, on the Incidence of Bacteraemia during the Pre-Engraftment Period of Allogenic Hematopoietic Stem Cell Transplantation

Claudie Roy, MD, Simon Frédéric Dufresne, MD FRCP, Miguel Chagnon, M.Sc, P.Stat, Silvy Lachance, MD FRCP

Blood (2018) 132 (Supplement 1): 2094.

https://doi.org/10.1182/blood-2018-99-119525

Published: 2018

Journal Articles

Second Bacteremia During Antibiotic Treatment In Children With Acute Myeloid Leukemia: A Report From The Canadian Infections In AML Research Group

Thai Hoa Tran, Rochelle Yanofsky, MD, FRCP(C), Donna Johnston, MD, FRCPC, David Dix, MD, Biljana Gillmeister, Marie-Chantal Ethier, BSc, Carol Portwine, Victoria E. Price, MBChB, MD, David Mitchell, Sonia Cellot, MD, Victor A. Lewis, MD, Shayna Zelcer, MD, Mariana Silva, MD, Bruno Michon, MD, FRCPC, Lynette Bowes, MD, Kent Stobart, MD, MSC, Josee Brossard, MD, Joseph Beyene, PhD, Lillian Sung, MD, PhD

Blood (2013) 122 (21): 1415.

https://doi.org/10.1182/blood.V122.21.1415.1415

Published: 2013

Journal Articles

Prophylactic Levofloxacin In Pediatric Neutropenic Patients During Autologous Hematopoietic Stem Cell Transplantation (HSCT)

Hanafy Ahmed Hafez, Dalia Yousef, Maggie Abbassi, Yasser Elborai, Alaa Elhaddad, MD

Blood (2013) 122 (21): 5462.

https://doi.org/10.1182/blood.V122.21.5462.5462

Published: 2013

Journal Articles

The Effect Of Donor and Recipient Statin Treatment On Infections After Allogeneic Hematopoietic Cell Transplantation

Sachiko Seo, MD, Michael Boeckh, MD, Barry E. Storer, PhD, Mark M Schubert, DDS, MSD, Marcello Rotta, MD, Brenda M. Sandmaier, MD, Marco Mielcarek, MD

Blood (2013) 122 (21): 4548.

https://doi.org/10.1182/blood.V122.21.4548.4548

Published: 2013

Journal Articles

Anti-Platelet Factor 4/Heparin Antibodies in Patients with Gram Negative Bacteremia

Georgios Pongas, MD, Swapan Dasgupta, PhD, Perumal Thiagarajan, MD

Blood (2012) 120 (21): 3391.

https://doi.org/10.1182/blood.V120.21.3391.3391

Published: 2012

Journal Articles

Association Analysis of Polymorphisms and Epistasis of Genes of IL-6, IL-10 and TNF-a in Patients with MM Submitted to ASCT

Fernanda M B Trigo, PharmD, Marcelo Luizon Rizzatti, PhD, Hélio Dutra, PhD, Maria Helena S Scaffo, Aguinaldo Luizon Simões, MD, PhD, Angelo Maiolino, MD, PhD, M. Nucci, MD, PhD, Belinda Pinto Simoes, MD, PhD

Blood (2012) 120 (21): 2026.

https://doi.org/10.1182/blood.V120.21.2026.2026

Published: 2012

Journal Articles

Palifermin In High Dose Chemotherapy and Autologous Stem Cell Transplantation: Reduction of Infections and of Resources Utilization with No Increase in Overall Cost

Giuseppe Milone, MD, Massimo Poidomani, MD, Salvatore Leotta, MD, Valeria Pinto, MD, Andrea Spadaro, Rita Lombardo, MD, Giovanni Tripepi, MD

Blood (2011) 118 (21): 4568.

https://doi.org/10.1182/blood.V118.21.4568.4568

Published: 2011

Journal Articles

Evaluation of Early Discharge After Hospital Treatment of Neutropenic Fever In Acute Myelogenous Leukemia (AML).

Victor A. Chow, Kathleen Shannon Dorcy, RN, MN, Ph.C, Stephen H. Petersdorf, MD, Kelda M. Gardner, PA-C, Pamela S. Becker, MD, PhD, Roland B. Walter, MD, PhD, John M. Pagel, MD, PhD, Paul C. Hendrie, MD, PhD, Andrei R. Shustov, MD, Janis L. Abkowitz, MD, Frederick R. Appelbaum, MD, Elihu H. Estey, MD

Blood (2010) 116 (21): 3806.

https://doi.org/10.1182/blood.V116.21.3806.3806

Published: 2010

Journal Articles

Rituximab Administration within 6 Months of Allogeneic SCT Carries Risk of Prolonged and Life Threatening Cytopenias.

Zachariah A. McIver, DO, Nicole Stephens, BS, Nicolas Naguib, BS, Andrew Grim, BS, A. John Barrett, MD

Blood (2009) 114 (22): 793.

https://doi.org/10.1182/blood.V114.22.793.793

Published: 2009

Journal Articles

Lipopolysaccharide binding protein promoter variants influence the risk for Gram-negative bacteremia and mortality after allogeneic hematopoietic cell transplantation

Jason W. Chien, Michael J. Boeckh, John A. Hansen, Joan G. Clark

Blood (2008) 111 (4): 2462–2469.

https://doi.org/10.1182/blood-2007-09-101709

Published: 2008

Includes: Supplemental data

Journal Articles

Comparison of Outcomes in Elderly Patients with Non-Hodgkins Lymphoma Undergoing High-Dose Chemotherapy to Their Younger Counterparts: Greater Morbidity but No Significant Impact on Overall Survival.

Tanya M. Wildes, MD, Kristan M. Augustin, PharmD, Ravi Vij, MD, Nancy Bartlett, MD, John F. DiPersio, MD, PhD, Steven M. Devine, MD

Blood (2005) 106 (11): 2086.

https://doi.org/10.1182/blood.V106.11.2086.2086

Published: 2005

NARROW

A Phase Ib/II Study of the BCL-2 Inhibitor Venetoclax in Combination with Standard Intensive AML Induction/Consolidation Therapy with FLAG-IDA in Patients with Newly Diagnosed or Relapsed/Refractory AML

Impact of Primary Antibacterial Prophylaxis on Neutropenic Fever, Infections, and Antimicrobial Resistance in Newly Diagnosed AML Patients

Soluble C5b-9 As a Prognostic Biomarker for Thrombotic Microangiopathy at the Onset of Graft-Versus-Host Disease

Venetoclax in Combination with FLAG-IDA Chemotherapy (FLAG-V-I) for Fit, Relapsed/Refractory AML Patients: Interim Results of a Phase 1b/2 Dose Escalation and Expansion Study

Impact of Omitting Prophylactic Antibiotics, to Preserve Gut Microbiota, on the Incidence of Bacteraemia during the Pre-Engraftment Period of Allogenic Hematopoietic Stem Cell Transplantation

Second Bacteremia During Antibiotic Treatment In Children With Acute Myeloid Leukemia: A Report From The Canadian Infections In AML Research Group

Prophylactic Levofloxacin In Pediatric Neutropenic Patients During Autologous Hematopoietic Stem Cell Transplantation (HSCT)

The Effect Of Donor and Recipient Statin Treatment On Infections After Allogeneic Hematopoietic Cell Transplantation

Anti-Platelet Factor 4/Heparin Antibodies in Patients with Gram Negative Bacteremia

Association Analysis of Polymorphisms and Epistasis of Genes of IL-6, IL-10 and TNF-a in Patients with MM Submitted to ASCT

Palifermin In High Dose Chemotherapy and Autologous Stem Cell Transplantation: Reduction of Infections and of Resources Utilization with No Increase in Overall Cost

Evaluation of Early Discharge After Hospital Treatment of Neutropenic Fever In Acute Myelogenous Leukemia (AML).

Rituximab Administration within 6 Months of Allogeneic SCT Carries Risk of Prolonged and Life Threatening Cytopenias.

Lipopolysaccharide binding protein promoter variants influence the risk for Gram-negative bacteremia and mortality after allogeneic hematopoietic cell transplantation

Comparison of Outcomes in Elderly Patients with Non-Hodgkins Lymphoma Undergoing High-Dose Chemotherapy to Their Younger Counterparts: Greater Morbidity but No Significant Impact on Overall Survival.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only